65 results
6-K
TAK
Takeda Pharmaceutical Co
3 Jun 24
Current report (foreign)
6:45am
and health-related quality of life in individuals with NT1, as well as patient satisfaction with TAK-861 treatment.
There is no change in Takeda’s
S-8
EX-5.1
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
. For such purpose, we have examined the originals, certified or photostatic copies, or copies otherwise identified to our satisfaction of the Registration Statement
6-K
EX-99.1
vw4256 rb293ve
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
nvj ja7yw
31 May 22
Current report (foreign)
6:07am
S-8
EX-5.1
ggj sl9tkxtgjm
28 Oct 21
Registration of securities for employees
6:33am
6-K
EX-99.1
i3r713saer3 fgtgbu
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-4.2
fcmt g0emn8u3cv0goa
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.6
0uj7wz3 gnbp
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.4
1p7bvmn
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.7
xbvxo4s5
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.9
k2gfcn5
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.3
8r42m oew3a
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.5
4u0ably1sa0s8xt
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.1
kvubq94ph6luc 3xaye
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.8
mujpug8imzzj0b8dqk
9 Jul 20
Current report (foreign)
10:27am